NextCell Pharma AB (STO:NXTCL)
Sweden · Delayed Price · Currency is SEK 1.088
+0.008 (0.74%)
Sep 2, 2026, 5:08 PM CET
NextCell Pharma AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 |
Net Income | -42.11 | -38.79 | -35.14 | -41.96 | -39.81 | -34.55 |
Depreciation & Amortization | 2.5 | 2.49 | 2.52 | 0.97 | 0.45 | 0.46 |
Loss (Gain) From Sale of Assets | - | - | - | - | - | 0.14 |
Other Operating Activities | - | - | - | -0 | - | - |
Change in Accounts Receivable | -2.55 | -2.41 | -1.79 | 3.17 | -7.59 | -1.56 |
Change in Inventory | 0.22 | 0.22 | - | 0.25 | -0.02 | -0.77 |
Change in Accounts Payable | -4.14 | -3.6 | -3.47 | 5.26 | -1.03 | 0.64 |
Change in Other Net Operating Assets | 1.4 | 0.33 | -0.98 | -5.47 | 4.18 | 2.33 |
Operating Cash Flow | -44.68 | -41.76 | -38.86 | -37.78 | -43.83 | -33.31 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 |
Capital Expenditures | -1.63 | -4.81 | -4.18 | -0.08 | -4.1 | -7.59 |
Investment in Securities | -0.27 | -0.3 | -0.06 | -0 | -0 | -1.76 |
Other Investing Activities | -0 | -0 | -0 | - | - | - |
Investing Cash Flow | -1.9 | -5.11 | -4.24 | -0.08 | -4.1 | -9.35 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 |
Long-Term Debt Issued | - | - | 1.1 | 0.8 | 0.84 | 0.61 |
Total Debt Issued | 1.05 | 1.05 | 1.1 | 0.8 | 0.84 | 0.61 |
Net Debt Issued (Repaid) | 1.05 | 1.05 | 1.1 | 0.8 | 0.84 | 0.61 |
Issuance of Common Stock | 17.1 | 36.56 | 36.56 | 40.09 | - | - |
Other Financing Activities | -2.63 | -2.63 | -2.63 | -6.25 | - | - |
Financing Cash Flow | 15.53 | 34.99 | 35.03 | 34.63 | 0.84 | 0.61 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 |
Miscellaneous Cash Flow Adjustments | - | -0 | 0 | - | - | - |
Net Cash Flow | -31.05 | -11.89 | -8.07 | -3.23 | -47.09 | -42.05 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 |
Free Cash Flow | -46.31 | -46.57 | -43.05 | -37.86 | -47.92 | -40.9 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -429.66% | -473.62% | -389.04% | -335.70% | -343.41% | -656.63% |
Free Cash Flow Per Share | -0.37 | - | -0.56 | -0.93 | -1.39 | -1.19 |
Levered Free Cash Flow | - | - | -30.33 | -22.93 | -33.74 | -28.38 |
Unlevered Free Cash Flow | - | - | -30.33 | -22.93 | -33.74 | -28.37 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 |
Cash Interest Paid | 0 | 0 | 0 | 0 | 0 | 0.01 |
Change in Working Capital | -5.07 | -5.47 | -6.24 | 3.21 | -4.46 | 0.65 |